S
SS Innovations International, Inc.
SSIICIK 0001676163NasdaqNon-AcceleratedSmaller ReportingSurgical & Medical Instruments & ApparatusFloridaFY ends Dec 31
Period
FY 2025
Revenue
$42.48M
Net Income
$-12.13M
Total Assets
—
Equity
—
Shares Out
200.13M
Op. Cash Flow
$-18.54M
Business
SS Innovations International, Inc. is a commercial-stage surgical robotics company that develops and commercializes advanced, lower-cost robotic surgical systems to expand access to robotically assisted surgery. It designs, manufactures and markets the SSi Mantra surgical robotic system family (including the SSi Mantra 3), Mudra instruments, vision and tele‑mentoring/telesurgery software, and related accessories and training and maintenance services. Its offerings are organized around system hardware, instruments/accessories, software/XR and service support, and multiple selling models (outright, deferred and pay‑per‑procedure). The company primarily markets in India and other underserved regions and sells directly in India and through an expanding international distributor network.
Summary from filing dated 2025-04-15
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 42 | 21 | — | — | — | |
| Cost of revenue | −23 | −12 | −5 | −968,721 | — | |
| GROSS PROFIT | 20 | 8 | 725,528 | 489,594 | — | |
| Research & development expense | 4 | 2 | 1 | 83,282 | 1,000 | |
| Stock compensation expense | 8 | 14 | 10 | — | — | |
| Depreciation and amortization expense | 1 | 436,005 | 152,738 | — | — | |
| Selling, general and administrative expense | 15 | 10 | 10 | 3 | — | |
| TOTAL OPERATING EXPENSES | 28 | 27 | 21 | 6 | 1 | |
| Loss from operations | −8 | −19 | −20 | −6 | — | |
| Interest Expense | −1 | −973,235 | −894,621 | — | — | |
| Interest and other income, net | 1 | 798,000 | 290,313 | — | — | |
| TOTAL INCOME / (EXPENSE), NET | 33,087 | −175,235 | −604,308 | 77,729 | −77,274 | |
| LOSS BEFORE INCOME TAXES | −8 | −19 | −21 | −2 | −1 | |
| Income tax expense | 4 | — | — | — | — | |
| NET LOSS | −12 | −19 | −21 | −6 | −1 | |
| Net loss per share - basic (in Dollars per share) | −0.06 | −0.11 | −0.14 | −0.14 | −0.05 | |
| Net loss per share - diluted (in Dollars per share) | −0.06 | −0.11 | −0.14 | −0.14 | −0.05 | |
| Weighted average- basic shares (in Shares) | 190 | 171 | 145 | 41 | 28 | |
| Weighted average- diluted shares (in Shares) | 199 | 181 | 152 | 41 | 28 | |
| Foreign currency translation loss | −1 | −539,900 | −243,089 | 15,521 | — | |
| Retirement Benefit | −68,809 | −14,226 | −7,009 | — | — | |
| Retirement Benefit | 1,433 | — | — | — | — | |
| Income tax effects relating to retirement benefit | 20,037 | — | — | — | — | |
| TOTAL OTHER COMPREHENSIVE LOSS | −1 | −554,126 | — | — | — | |
| TOTAL COMPREHENSIVE LOSS | −13 | −20 | −21 | −6 | — |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 3 | 466,500 | 2 | 2 | 405,774 | |
| Restricted cash | 6 | 6 | 5 | 63,492 | — | |
| Accounts receivable, net | 12 | 4 | 2 | 592,313 | — | |
| Inventory, net | 17 | 10 | 7 | 855,777 | — | |
| Prepaids and other current assets | 10 | 6 | 5 | 700,920 | — | |
| Total Current Assets | 49 | 27 | 21 | 7 | 408,065 | |
| Property, plant, and equipment, net | 9 | 5 | 706,405 | 388,820 | 20,542 | |
| Right of use asset | 3 | 3 | 3 | — | — | |
| Deferred tax assets, net | 533,727 | — | — | — | — | |
| Accounts receivable, net | 9 | 3 | 2 | — | — | |
| Restricted cash | 458,964 | 318,527 | 35,919 | — | — | |
| Prepaids and other non current assets | 4 | 3 | 4 | — | — | |
| Total Assets | 74 | 42 | 32 | 9 | 428,607 | |
| Bank overdraft facility | 11 | 8 | 6 | 3 | — | |
| Notes payable | — | 7 | — | — | — | |
| Current portion of operating lease liabilities | 579,169 | 409,518 | 396,784 | — | — | |
| Accounts payable | 5 | 2 | 901,552 | 618,852 | 124,581 | |
| Deferred revenue | 3 | 1 | 156,330 | — | — | |
| Accrued expenses & other current liabilities | 6 | 2 | 489,939 | 253,377 | — | |
| Total Current Liabilities | 26 | 21 | 8 | 11 | 287,281 | |
| Operating lease liabilities, less current portion | 2 | 2 | 2 | — | — | |
| Deferred Revenue | 7 | 5 | 939,150 | — | — | |
| Other non current liabilities | 288,764 | 74,817 | 33,933 | — | — | |
| Total Liabilities | 36 | 29 | 12 | 11 | — | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock, authorized 5,000,000 shares of Series A, Non-Convertible Preferred Stock, $0.0001 par value per share; 1,000 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 1 | 1 | 1 | — | — | |
| Common stock, 250,000,000 shares authorized, $0.0001 par value, 194,165,141 shares and 171,579,284 shares issued and outstanding as of December 31, 2025 and December 31, 2024 respectively | 19,416 | 17,157 | 17,072 | 5,389 | 3,785 | |
| Accumulated other comprehensive income (loss) | −2 | −749,625 | −195,499 | 899,917 | — | |
| Additional paid in capital | 95 | 57 | 43 | 11 | 8 | |
| Capital reserve | 899,917 | 899,917 | 899,917 | — | — | |
| Accumulated deficit | −56 | −44 | −25 | −14 | −8 | |
| Total stockholders equity | 38 | 13 | 20 | −3 | −166,380 | |
| Total liabilities and stockholders equity | 74 | 42 | 32 | 9 | 428,607 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Operating lease expense | 827,521 | 753,449 | 560,668 | — | — | |
| Interest Expense | 271,633 | 317,234 | — | — | — | |
| Interest and other income, net | −625,883 | −418,426 | −290,313 | — | — | |
| Property, plant and equipment written off | — | 48,456 | 9,250 | — | — | |
| Provision for credit loss reserve, net | 324,345 | 955,762 | — | — | — | |
| Deferred income tax benefit | −512,865 | — | — | — | — | |
| Provision for slow moving inventory | −110,332 | — | — | — | — | |
| Accounts receivable, net | −13 | −5 | −3 | — | — | |
| Inventory, net | −8 | −8 | −6 | — | — | |
| Deferred revenue | 4 | 5 | 1 | — | — | |
| Prepaids and other assets | −5 | −1 | −3 | −1 | — | |
| Accounts payable | 3 | 1 | 736,075 | — | — | |
| Income taxes payable, net | 4 | — | — | — | — | |
| Accrued expenses & other liabilities | 161,914 | 1 | — | — | — | |
| Operating lease payment | −792,166 | −705,868 | −524,766 | — | — | |
| Net cash used in operating activities | −19 | −10 | −15 | −6 | −363,034 | |
| Purchase of property, plant and equipment | −4 | −661,479 | −453,327 | −220,324 | — | |
| Net cash used in investing activities | −4 | −661,479 | −453,327 | −3 | 38,150 | |
| Proceeds from bank overdraft facility (net) | 3 | 2 | 2 | 3 | — | |
| Proceeds from issuance of promissory notes to principal shareholder | — | 3 | — | 3 | — | |
| Proceeds from issuance of convertible notes to principal shareholder | 28 | 3 | 17 | 4 | — | |
| Proceeds from issuance of convertible notes to other investors | — | 1 | 3 | — | — | |
| Repayment of convertible notes to principal shareholder, including interest | −4 | — | — | — | — | |
| Repayment of convertible notes to other investors, including interest | −1 | — | −126,505 | — | — | |
| Net cash provided by financing activities | 26 | 9 | 23 | 9 | 569,949 | |
| Net change in cash | 4 | −738,529 | 7 | 1 | 245,065 | |
| Effect of exchange rate on cash | −985,026 | 274,219 | −168,094 | 69,189 | — | |
| Conversion of convertible notes into common stock, including interest | 31 | — | — | — | — | |
| Transfer of systems from inventory to property, plant and equipment | 2 | 5 | — | — | — | |
| Transfer of systems from property, plant and equipment to inventory | 1 | — | — | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro